IRIS UniCatt

Hohaus, Stefan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.428
NA - Nord America 5.807
AS - Asia 2.419
SA - Sud America 449
AF - Africa 58
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.734
DE - Germania 2.196
SE - Svezia 1.095
CN - Cina 1.023
SG - Singapore 790
PL - Polonia 682
IT - Italia 625
UA - Ucraina 450
BR - Brasile 407
FR - Francia 326
GB - Regno Unito 254
IE - Irlanda 247
FI - Finlandia 214
IN - India 185
ID - Indonesia 156
RU - Federazione Russa 113
TR - Turchia 58
CA - Canada 53
CI - Costa d'Avorio 34
VN - Vietnam 34
AT - Austria 33
BE - Belgio 33
JP - Giappone 27
NL - Olanda 27
KR - Corea 26
CZ - Repubblica Ceca 22
AU - Australia 21
IR - Iran 21
CH - Svizzera 18
HK - Hong Kong 15
LT - Lituania 13
GR - Grecia 12
MX - Messico 12
BD - Bangladesh 11
ES - Italia 11
RO - Romania 11
AR - Argentina 10
CO - Colombia 9
IL - Israele 9
LV - Lettonia 8
AE - Emirati Arabi Uniti 7
EC - Ecuador 7
MY - Malesia 7
UZ - Uzbekistan 7
IQ - Iraq 6
MA - Marocco 6
PK - Pakistan 6
ZA - Sudafrica 6
NO - Norvegia 5
PE - Perù 5
BG - Bulgaria 4
DK - Danimarca 4
HU - Ungheria 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
CL - Cile 3
CU - Cuba 3
EG - Egitto 3
EU - Europa 3
KE - Kenya 3
SA - Arabia Saudita 3
VE - Venezuela 3
CY - Cipro 2
DZ - Algeria 2
GE - Georgia 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
LK - Sri Lanka 1
MK - Macedonia 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
Totale 15.187
Salva come PNG Salva come JPEG
Città #
Chandler 1.050
Warsaw 666
Singapore 485
Ashburn 434
Jacksonville 342
Dublin 241
San Mateo 226
Nanjing 221
Ann Arbor 207
Fairfield 199
Woodbridge 197
Dearborn 195
Houston 193
Munich 182
Wilmington 182
Jakarta 153
New York 141
Milan 130
Nürnberg 128
Seattle 107
Helsinki 101
Los Angeles 100
Rome 100
Cattolica 98
Bremen 89
Beijing 84
Moscow 84
Nanchang 84
Redmond 77
Boston 75
Lawrence 73
Chicago 70
Redwood City 69
The Dalles 63
Princeton 58
Kunming 57
Marseille 56
Hyderabad 54
Frankfurt am Main 50
Cambridge 47
Lancaster 46
Hefei 45
Izmir 39
Shanghai 38
Norwalk 35
Abidjan 34
Hangzhou 33
Hebei 33
São Paulo 32
Guangzhou 31
London 31
Brussels 30
Mountain View 30
Shenyang 30
Zhengzhou 30
Boardman 28
Jiaxing 28
Seoul 26
Tianjin 26
Changsha 25
Nuremberg 25
Auburn Hills 24
Fremont 24
Leawood 24
University Park 21
Düsseldorf 20
Toronto 20
Belo Horizonte 18
Santa Clara 18
Jinan 16
Vienna 16
Augusta 15
Portsmouth 15
Pune 15
Florence 14
Hanoi 14
Brno 13
Falls Church 13
Rio de Janeiro 13
Costa Mesa 12
Lauterbourg 12
Dong Ket 11
Turku 11
Hong Kong 10
Lanzhou 10
Philadelphia 10
Andover 9
Berlin 9
Campinas 9
Monmouth Junction 9
Brooklyn 8
Buffalo 8
Kish 8
Las Vegas 8
Naples 8
Ottawa 8
Phoenix 8
San Diego 8
Simi Valley 8
Sydney 8
Totale 8.348
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 372
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 310
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 294
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 279
Fanconi anemia gene variants in therapy-related myeloid neoplasms 275
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 245
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 241
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 218
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 217
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 189
Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma 186
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 184
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 174
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 171
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 163
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 157
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 150
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 146
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 146
Why methylation is not a marker predictive of response to hypomethylating agents 143
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 142
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 140
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 139
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 138
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 137
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 137
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 132
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 132
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 132
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 127
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 127
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 125
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 121
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 121
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 120
Epigenetic changes in therapy-related MDS/AML 118
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 118
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 118
Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). 118
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 117
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 117
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 117
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 116
Iron in Hodgkin's lymphoma 116
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 114
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 113
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 113
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 111
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 110
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 109
PU.1 and CEBPA expression in acute myeloid leukemia. 109
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 108
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma. 108
Primary multifocal lymphoma of peripheral nervous system: Case report and review of the literature 107
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 105
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 105
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 105
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 103
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 103
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 102
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 101
Outcome of therapy-related myeloid neoplasms treated with azacitidine 101
Clinical and prognostic features of lymphomas arising in the head and neck region: Our experience of preferential association of different histotypes with various sites of origin in ninety patients 101
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 101
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 101
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 100
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 99
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 99
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 98
Clonal evolution in therapy-related neoplasms 97
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 97
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 95
Small lymphocytic lymphoma in a patient with Fabry disease 94
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 94
Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study. 92
Mantle cell lymphoma relapsing at the lymphedematous arm 92
Prognostic factors in hodgkin lymphoma 92
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 92
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 91
Desensitization to thalidomide in a patient with multiple myeloma 90
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 89
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 89
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 88
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 88
Small lymphocytic lymphoma in a patient with Fabry disease 85
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 85
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 85
Dural MALT Lymphoma Detected by 11C-Methionine PET/CT 85
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 84
Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine 84
Burkitt's lymphoma of the breast metastatic to the ovary diagnosed during pregnancy 82
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 82
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 81
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 81
Cardiovascular involvement in patients affected by multiple myeloma: a comprehensive review of recent advances 81
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 80
Muscle Recurrence of a Primarily Nodal Follicular Lymphoma Studied by Contrast-Enhanced 18F-FDG PET/CT 80
Cognitive Decline in Older Long-Term Survivors From Non-Hodgkin Lymphoma: A Multicenter Cross-Sectional Study 80
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 80
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 77
Totale 12.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020344 0 0 0 0 0 0 0 0 0 0 209 135
2020/20211.524 50 183 52 126 180 147 178 37 148 83 289 51
2021/20221.308 153 112 22 54 86 36 38 207 64 105 210 221
2022/20232.890 390 401 205 507 179 357 142 230 306 48 85 40
2023/20241.308 56 388 42 66 39 207 52 87 11 39 152 169
2024/20252.846 97 114 251 159 299 119 229 167 458 291 662 0
Totale 15.399